Company: INMB
Filing Date: 2025-12-08
Form Type: 8-A12B/A
Source: 0001213900-25-119251
Chunk: 2

Company: Inmune Bio, Inc.
Filing Date: 2025-12-08
Form: 8-A12B/A
Chunk 2
---
14, 2023, between INmune Bio Inc. and Vstock Transfer LLC (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on December 18, 2023)      |
| 4.5            |     | Amendment No. 4 to Rights Agreement, dated as of December 5, 2025, between INmune Bio Inc. and Vstock Transfer LLC (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on December 9, 2024)        |
| 4.6            |     | Amendment No. 5 to Rights Agreement, dated as of December 5, 2025, between INmune Bio Inc. and Vstock Transfer LLC (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on December 8, 2025)        |

<div align='center'>2

SIGNATURE</div>

Pursuant to the requirements
of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.

| Date: December 8, 2025 | INMUNE BIO INC. |                         |
|:-----------------------|:----------------|:------------------------|
|                        | By:             | /s/ David Moss          |
|                        | Name:           | David Moss              |
|                        | Title:          | Chief Executive Officer |

<div align='center'>3</div>